1. Home
  2. MDGL vs R Comparison

MDGL vs R Comparison

Compare MDGL & R Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • R
  • Stock Information
  • Founded
  • MDGL 2011
  • R 1933
  • Country
  • MDGL United States
  • R United States
  • Employees
  • MDGL N/A
  • R N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • R Rental/Leasing Companies
  • Sector
  • MDGL Health Care
  • R Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • R Nasdaq
  • Market Cap
  • MDGL 6.1B
  • R 6.0B
  • IPO Year
  • MDGL N/A
  • R N/A
  • Fundamental
  • Price
  • MDGL $314.31
  • R $175.52
  • Analyst Decision
  • MDGL Strong Buy
  • R Buy
  • Analyst Count
  • MDGL 9
  • R 7
  • Target Price
  • MDGL $420.63
  • R $172.83
  • AVG Volume (30 Days)
  • MDGL 282.4K
  • R 306.2K
  • Earning Date
  • MDGL 08-06-2025
  • R 07-24-2025
  • Dividend Yield
  • MDGL N/A
  • R 1.84%
  • EPS Growth
  • MDGL N/A
  • R 49.59
  • EPS
  • MDGL N/A
  • R 11.48
  • Revenue
  • MDGL $317,383,000.00
  • R $12,669,000,000.00
  • Revenue This Year
  • MDGL $286.17
  • R $2.98
  • Revenue Next Year
  • MDGL $64.17
  • R $4.08
  • P/E Ratio
  • MDGL N/A
  • R $15.33
  • Revenue Growth
  • MDGL N/A
  • R 6.20
  • 52 Week Low
  • MDGL $200.63
  • R $120.84
  • 52 Week High
  • MDGL $377.46
  • R $177.40
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 64.53
  • R 73.69
  • Support Level
  • MDGL $284.02
  • R $168.86
  • Resistance Level
  • MDGL $311.21
  • R $177.40
  • Average True Range (ATR)
  • MDGL 11.94
  • R 4.03
  • MACD
  • MDGL 2.74
  • R 1.42
  • Stochastic Oscillator
  • MDGL 100.00
  • R 93.27

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About R Ryder System Inc.

Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.

Share on Social Networks: